Tendinopathy after ofloxacin ear drops.
Regional Pharmacovigilance Centre of Burgundy, 14 rue Paul Gaffarel, EA 4184, 21079, Dijon, France. aurelie.grandvuillemin@chu-dijon.fr.
Aurélie
A
Grandvuillemin
Rheumatology-University Hospital, 14 rue Paul Gaffarel, BP 77908, 21079, Dijon, France.
Elise
E
Contant
Department of Pharmacology and Pharmacovigilance, CHU, Avenue de la Côte de Nacre, 14033, Caen, France.
Sophie
S
Fedrizzi
Regional Pharmacovigilance Center of Picardy, Avenue René Laënnec-Salouel, 80054, Amiens, France.
Valérie
V
Gras
Regional Pharmacovigilance Centre of Burgundy, 14 rue Paul Gaffarel, 21079, Dijon, France.
Anne
A
Dautriche
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000009:adverse effects*; D019999:Pharmaceutical Solutions; D052256:Tendinopathy / Q000139:chemically induced*
D000900:Anti-Bacterial Agents; D019999:Pharmaceutical Solutions; D015242:Ofloxacin